UDG Healthcare increases its 2018 interim dividend by 19%
UDG Healthcare 2018 interim results
adjusted diluted earnings per share (EPS) increased by 24% (21% on a constant currency basis).
Guidance reiterated for FY18 constant currency adjusted EPS1 growth of between 18% and 21% over last year's EPS of 37.1 $ cent.
Net revenue growth of 17% (11% on a constant currency basis) to $568.7 million.
Adjusted operating profit1 growth of 15% (11% on a constant currency basis) to $67.4 million. Adjusted net operating margin2 declined marginally from 12.0% to 11.8%.
Adjusted profit before tax1 up 19% (16% on a constant currency basis).
Ashfield's operating profit1 increased by 25% (18% on a constant currency basis) driven by the benefit of acquisitions completed in FY17. Ashfield would have generated 6% underlying operating profit growth during the period if the impact of Future Fit was excluded.
Sharp's operating profit was 2% behind the prior period. A good second quarter trading performance did not fully offset a weak first quarter.
Net debt of $46.6 million at 31 March 2018 (0.28 times net debt to EBITDA), providing significant capacity to execute strategic acquisitions.
19% increase in interim dividend to 4.25 $ cent per share.
Shoe Zone 2018 final results
Workspace 2019 interim resultsRead more
Avon Rubber 2018 final resultsRead more
Adept technology 2019 interim resultsRead more
Land Securities 2018 interim resultsRead more
B&M European value retail 2019 interim resultsRead more
Softcat 2018 final resultsRead more
Bellway 2018 final resultsRead more